Syed H. Omar, Christopher J. Scott, Adam S. Hamlin, Hassan K. Obied 

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Etiopathogenesis of Alzheimer's disease
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
Decision Making as a Window on Cognition Michael N. Shadlen, Roozbeh Kiani Neuron Volume 80, Issue 3, Pages (October 2013) DOI: /j.neuron
Under the supervision of miklós jászberényi
Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease Nobutaka Hirokawa, Shinsuke Niwa, Yosuke Tanaka.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Mechanisms of Age-Related Macular Degeneration Jayakrishna Ambati, Benjamin J. Fowler Neuron Volume 75, Issue 1, Pages (July 2012) DOI: /j.neuron
Volume 29, Issue 1, Pages 1-7 (January 2013)
Karen M. Strat, Thomas J. Rowley, Andrew T. Smithson, Jeffery S
Yasuaki Wada, Bo Lönnerdal  Journal of Nutritional Biochemistry 
Maharshi Bhaswant, Hemant Poudyal, Lindsay Brown 
Yasuaki Wada, Bo Lönnerdal  Journal of Nutritional Biochemistry 
Nutritional therapy for nonalcoholic fatty liver disease
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Mubeen Ahmad Ansari, Hafiz Mohammad Abdul, Gururaj Joshi, Wycliffe O
Alzheimer’s Disease CNS Block.
Oxidants and antioxidants in alcohol-induced liver disease
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
The Neuropathology and Neurobiology of Traumatic Brain Injury
Is Early Placement Better in Alzheimer's Disease?
The Neuropathology and Neurobiology of Traumatic Brain Injury
Immunotherapeutic Approaches for Alzheimer’s Disease
Nat. Rev. Neurol. doi: /nrneurol
Oxidants and antioxidants in alcohol-induced liver disease
Acute Pancreatitis: Bench to the Bedside
Acetylation Unleashes Protein Demons of Dementia
Michele Curcio, Frank Bradke  Neuron 
Oxidative stress in Alzheimer's disease
Testing the Amyloid Hypothesis with a Humanized AD Mouse Model
Safia Costes, Peter C. Butler  Cell Metabolism 
Oxidative stress in autism
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Sophie Stukas, Jérôme Robert, Cheryl L. Wellington  Cell Metabolism 
Volume 17, Issue 4, Pages (April 2013)
Amyloid Structures from Alzheimer’s Disease Patients
Volume 72, Issue 1, Pages 9-21 (October 2011)
Soledad Matus, Danilo B. Medinas, Claudio Hetz  Cell Stem Cell 
α-Synuclein and Tau: Mitochondrial Kill Switches
Anti-Tau Antibodies: Hitting the Target
Applying the Brakes: When to Stop Eating
Tara L. Spires-Jones, Bradley T. Hyman  Neuron 
Todd E. Golde, Lon S. Schneider, Edward H. Koo  Neuron 
Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle
Michele Curcio, Frank Bradke  Neuron 
The Role of Apolipoprotein E in Alzheimer's Disease
Acute Pancreatitis: Bench to the Bedside
Scott A. Small, Karen Duff  Neuron 
Volume 91, Issue 1, Pages 1-3 (July 2016)
Elucidating the Role of TREM2 in Alzheimer’s Disease
Glucose Metabolism: A Sweet Relief of Alzheimer’s Disease
A Ceramide-Centric View of Insulin Resistance
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Amyloid Structures from Alzheimer’s Disease Patients
Fyn-Tau-Amyloid: A Toxic Triad
Anaesthesia for peculiar cells'a century of sickle cell disease
Alzheimer Mechanisms and Therapeutic Strategies
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Eystein S. Husebye, Mark S. Anderson  Immunity 
Chapter 18 Dietary Phytochemicals in Neurodegenerative Disease
Eystein S. Husebye, Mark S. Anderson  Immunity 
How does brain insulin resistance develop in Alzheimer's disease?
Volume 16, Issue 3, Pages (September 2012)
A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress  Benjamin Guy Trist, Dominic.
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

The protective role of plant biophenols in mechanisms of Alzheimer's disease  Syed H. Omar, Christopher J. Scott, Adam S. Hamlin, Hassan K. Obied  Journal of Nutritional Biochemistry  Volume 47, Pages 1-20 (September 2017) DOI: 10.1016/j.jnutbio.2017.02.016 Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 1 Schematic diagram illustrating AD pathology and the potential role of biophenols. (a) In amyloidogenic pathway, enzymatic action (β-secretase) producing extracellular Aβ peptide and ultimately leads to AD. Biophenols covalently bond to Aβ and inhibit their further aggregation. (b) Soluble tau attached with the microtubules and supports axonal transport, became hyperphosphorylated in AD, caused detachment of tau from microtubules and led to formation of neurofibrillary tangles and, ultimately, neuronal death followed by cognition impairment. Biophenols inhibited the tau fibrillization or aggregation along with inhibition of unfolding of tau from microtubule and ceases further tangle formation. (c) Increase in production of free radicals leading to disrupt the equilibrium between production and clearance of RONS, causing neuronal hypoxia and degeneration and, ultimately, involved in the pathogenesis of AD. Biophenols reduces the RONS production and oxidative stress. (d) Altered mitochondrial enzyme release causes defect in ETC, leading to produce increased RONS and altered calcium homeostasis. Biophenols inhibited the increase in RONS production which ultimately leads to decrease in production of Aβ. Journal of Nutritional Biochemistry 2017 47, 1-20DOI: (10.1016/j.jnutbio.2017.02.016) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 2 Chemical structures of important biophenols with anti-AD activities. Journal of Nutritional Biochemistry 2017 47, 1-20DOI: (10.1016/j.jnutbio.2017.02.016) Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 3 A holistic approach is required to evaluate the anti-AD properties of phytochemicals where activity is examined at cellular, tissue and functional levels. Journal of Nutritional Biochemistry 2017 47, 1-20DOI: (10.1016/j.jnutbio.2017.02.016) Copyright © 2017 Elsevier Inc. Terms and Conditions

Journal of Nutritional Biochemistry 2017 47, 1-20DOI: (10. 1016/j Journal of Nutritional Biochemistry 2017 47, 1-20DOI: (10.1016/j.jnutbio.2017.02.016) Copyright © 2017 Elsevier Inc. Terms and Conditions